Perioperative Aspirin Usage Survey

• Sponsor: University of New Mexico (Other)
• Overall Status: Completed
• CT.gov ID: NCT02561507
• Collaborator: (none)
• Enrollment: 150
• Location: 1
• Duration (Months): 7
• Patients Per Site Per Month: 21.4

Study Details

Study Description

Brief Summary

This is a survey of members of the American College of Surgeons (ACS), to describe and explore current patterns of their decisions about withholding or continuation for patients taking aspirin (ASA) in the perioperative period. Secondarily, the survey will also explore surgeons' knowledge about the risks and benefits attending this decision, and about national organizations' recommendations.

Condition or Disease	Intervention/Treatment	Phase
Surgery; Cardiovascular Disease	Behavioral: Survey

Detailed Description

An announcement of the survey and invitation to participate will be posted in the "ACS Surgery News" newsletter published by the American College of Surgeons. Surgeons of all specialties will be invited to participate. No identifiers will be maintained with survey responses. In addition to the substantive questions below, typical demographic data will be obtained including participants' duration of practice, specialty, gender, state, etc.

The survey will include questions intended to characterize current practice surrounding the decision to continue or withhold aspirin in the perioperative period. Other questions will focus on surgeons' knowledge of national medical/surgical organizations that have published guidelines on the perioperative use of aspirin. Finally, other survey questions will characterize surgeons' knowledge of the platelet rebound effect.

Study Design

• Study Type: Observational
• Actual Enrollment: 150 participants
• Observational Model: Cohort
• Time Perspective: Prospective
• Official Title: Use of Aspirin in the Perioperative Setting: A Surgeon's Survey
• Study Start Date: Oct 1, 2015
• Actual Primary Completion Date: Apr 1, 2016
• Actual Study Completion Date: May 1, 2016

Arms and Interventions

Arm	Intervention/Treatment
American College of Surgeons members Survey participants	Behavioral: Survey

Outcome Measures

Primary Outcome Measures

1. Typical proportion of participants' patients given a recommendation to stop taking aspirin [At time of survey; generally less than 20 minutes]

2. Proportion of participants correctly identifying national organizations with perioperative aspirin recommendations [At time of survey; generally less than 20 minutes]

3. Proportion of participants correctly answering questions about platelet rebound effect [At time of survey; generally less than 20 minutes]

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: Yes

Inclusion Criteria:

• Members of the American College of Surgeons

Exclusion Criteria:

• None

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	University of New Mexico Hospital	Albuquerque	New Mexico	United States	87106

Sponsors and Collaborators

• University of New Mexico

Investigators

• Principal Investigator: Neal Gerstein, MD, University of New Mexico

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Neal Gerstein, Associate Professor, University of New Mexico
• ClinicalTrials.gov Identifier: NCT02561507
• Other Study ID Numbers: 15-215
• First Posted: Sep 28, 2015
• Last Update Posted: Oct 26, 2016
• Last Verified: Oct 1, 2016

• Additional relevant MeSH terms: Cardiovascular Diseases

Study Results

No Results Posted as of Oct 26, 2016